Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

ConditionCervical Intraepithelial Neoplasia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorFondazione IRCCS Istituto Nazionale dei Tumori, Milano

About this trial

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Treatment of HPV-related disease

Disqualifiers

Previous HPV vaccination

Trial population

Pateints with HPV-related disease

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

600 Participants

are grouped into 1 trial group

Group A: treatment of HPV-related disease with or without vaccination

Trial outcomes

Primary outcomes

HPV recurrence

Time frame

2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Lead sponsor

Source ClinicalTrials.gov

Apply now